The Antimicrobial Insect Peptide CopA3 Blocks Ethanol-Induced Liver Inflammation and Liver Cell Injury in Mice
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Alcoholic liver disease (ALD), which encompasses alcoholic steatosis, alcoholic hepatitis, and alcoholic cirrhosis, is a major cause of morbidity and mortality worldwide. Although the economic and health impacts of ALD are clear, few advances have been made in its prevention or treatment. We recently demonstrated that the insect-derived antimicrobial peptide CopA3 exerts anti-apoptotic and anti-inflammatory activities in various cell systems, including neuronal cells and colonic epithelial cells. Here, we tested whether CopA3 inhibits ethanol-induced liver injury in mice. Mice were intraperitoneally injected with ethanol only or ethanol plus CopA3 for 24 h and then liver injury and inflammatory responses were measured. Ethanol enhanced the production of proinflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, interferon (IFN)-γ, and IL-10. It also induced hepatocyte apoptosis and ballooning degeneration in hepatocytes. Notably, all these effects were eliminated or significantly reduced by CopA3 treatment. Collectively, our findings demonstrate that CopA3 ameliorates ethanol-induced liver cell damage and inflammation, suggesting the therapeutic potential of CopA3 for treating ethanol-induced liver injury.
Abstract
Alcoholic liver disease (ALD), which encompasses alcoholic steatosis, alcoholic hepatitis, and alcoholic cirrhosis, is a major cause of morbidity and mortality worldwide. Although the economic and health impacts of ALD are clear, few advances have been made in its prevention or treatment. We recently demonstrated that the insect-derived antimicrobial peptide CopA3 exerts anti-apoptotic and anti-inflammatory activities in various cell systems, including neuronal cells and colonic epithelial cells. Here, we tested whether CopA3 inhibits ethanol-induced liver injury in mice. Mice were intraperitoneally injected with ethanol only or ethanol plus CopA3 for 24 h and then liver injury and inflammatory responses were measured. Ethanol enhanced the production of proinflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, interferon (IFN)-γ, and IL-10. It also induced hepatocyte apoptosis and ballooning degeneration in hepatocytes. Notably, all these effects were eliminated or significantly reduced by CopA3 treatment. Collectively, our findings demonstrate that CopA3 ameliorates ethanol-induced liver cell damage and inflammation, suggesting the therapeutic potential of CopA3 for treating ethanol-induced liver injury.
참고문헌 (35)
- Chacko KR, "Spectrum of alcoholic liver disease", Clin. Liver Dis, 20, pp.419~427 (2016)
- Farooq MO, "Pathogenesis and management of alcoholic liver disease", Dig. Dis, 34, pp.347~355 (2016)
- Lackner C, "Fibrosis and alcohol-related liver disease", J. Hepatol, 70, pp.294~304 (2019)
- Petrasek J, "IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice", J. Clin. Invest, 122, pp.3476~3489 (2012)
- Neuman MG, "Alcoholic and non-alcoholic steatohepatitis", Exp. Mol. Pathol, 97, pp.492~510 (2014)
- Navarro CDC, "Redox imbalance due to the loss of mitochondrial NAD(P)-transhydrogenase markedly aggravates high fat diet-induced fatty liver disease in mice", Free Radic. Biol. Med, 113, pp.190~202 (2017)
- Tilg H, "Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis", J. Hepatol, 38, pp.419~425 (2003)
- Gonzalez-Reimers E, "Relation between body fat and liver fat accumulation and cytokine pattern in non-alcoholic patients with chronic HCV infection", Ann. Nutr. Metab, 55, pp.351~357 (2009)
- Neuman MG, "Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C", Clin. Biochem, 34, pp.173~182 (2001)
- Singal AK, "Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis : exploratory analysis from the UNOS database", Hepatology, 55, pp.1398~1405 (2012)
- Wilkinson PK, "Arterial-venous blood alcohol concentration gradients", J. Pharmacokinet. Biopharm, 9, pp.279~307 (1981)
- Cederbaum AI, "Alcohol metabolism", Clin Liver Dis, 16, pp.667~685 (2012)
- Orrego H, "Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis", Gastroenterology, 92, pp.208~214 (1987)
- Shah ND, "Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide", Clin. Gastroenterol. Hepatol, 17, pp.2320~2329 (2019)
- Varma V, "Liver transplantation for alcoholic liver disease", World J. Gastroenterol, 16, pp.4377~4393 (2010)
- 김순자, "Synthetic Coprisin Analog Peptide, D-CopA3 has Antimicrobial Activity and Pro-Apoptotic Effects in Human Leukemia Cells", Journal of Microbiology and Biotechnology, 22(2), pp.264~269 (2012), 한국미생물·생명공학회
- Kim DH, "The insect peptide CopA3 increases colonic epithelial cell proliferation and mucosal barrier function to prevent inflammatory responses in the gut", J. Biol. Chem, 291, pp.3209~3223 (2015)
- Nam ST, "Insect peptide CopA3-induced protein degradation of p27Kip1stimulates proliferation and protects neuronal cells from apoptosis", Biochem. Biophys. Res. Commun, 437, pp.35~40 (2014)
- Nam HJ, "The insect peptide CopA3 inhibits lipopolysaccharide-induced macrophage activation", J. Pept. Sci, 18, pp.650~656 (2012)
- 윤이나, "An Analog of the Antimicrobial Peptide CopA5 Inhibits Lipopolysaccharide-Induced Macrophage Activation", Journal of Microbiology and Biotechnology, 27(2), pp.350~356 (2017), 한국미생물·생명공학회[DOI]
- Chao X, "Impaired TFEB-mediated lysosome biogenesis and autophagy promote chronic ethanol-induced liver injury and steatosis in mice", Gastroenterology, 155, pp.865~879 e812 (2018)
- Chen MM, "Intoxication by intraperitoneal injection or oral gavage equally potentiates postburn organ damage and inflammation", Mediators Inflamm, 2013, pp.971481~ (2013)
- Jamal M, "Ethanol and acetaldehyde after intraperitoneal administration to Aldh2-knockout mice-reflection in blood and brain levels", Neurochem. Res, 41, pp.1029~1034 (2016)
- Kawaguchi S, "Melanoma differentiation-associated gene 5 positively modulates TNF-α-induced CXCL10 expression in cultured HuH-7and HLE cells", Inflammation, 42, pp.2095~2104 (2019)
- Sasaki Y, "Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content", Sci. Rep, 10, pp.7818~ (2020)
- Chen P, "S-allyl-l-cysteine(SAC)protects hepatocytes from alcohol-induced apoptosis", FEBS. Open Bio, 9, pp.1327~1336 (2019)
- Verma VK, "Alcohol stimulates macrophage activation through caspasedependent hepatocyte derived release of CD40L containing extracellular vesicles", J. Hepatol, 64, pp.651~660 (2016)
- Neuman MG, "Alcoholic liver disease : Role of cytokines", Biomolecules, 5, pp.2023~2034 (2015)
- Thakur V, "Adiponectin normalizes LPS-stimulated TNF-α production by rat Kupffer cells after chronic ethanol feeding", Am. J. Physiol. Gastrointest. Liver Physiol, 290, pp.G998~1007 (2006)
- Kawaratani H, "The effect of inflammatory cytokines in alcoholic liver disease", Mediators Inflamm, 2013, pp.495156~ (2015)
- Kawaratani H, "Therapeutic strategies for alcoholic liver disease : Focusing on inflammation and fibrosis(Review)", Int. J. Mol. Med, 40, pp.263~270 (2017)
- Zhou Z, "Ethanol-induced apoptosis in mouse liver : Fas-and cytochrome c-mediated caspase-3 activation pathway", Am. J. Pathol, 159, pp.329~338 (2001)
- Sakhuja, P., "Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?", World J. Gastroenterol, 20, pp.16474~16479 (2014)
- Celli R, "Pathology of alcoholic liver disease", J. Clin. Transl. Hepatol, 2, pp.103~109 (2014)
- Lackner C, "Ballooned hepatocytes in steatohepatitis : the value of keratin immunohistochemistry for diagnosis", J. Hepatol, 48, pp.821~828 (2008)